These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Malignant ventricular arrhythmias in the subacute and late phases of myocardial infarction. Clinical arrhythmological characteristics and prognostic value]. Proclemer A, Facchin D, Fresco C, Bernardi G, Fontanelli A, Feruglio GA. G Ital Cardiol; 1990 May; 20(5):400-11. PubMed ID: 2210161 [Abstract] [Full Text] [Related]
44. Role of ischemic preconditioning and inflammatory response in the development of malignant ventricular arrhythmias after reperfused ST-elevation myocardial infarction. Kaneko H, Anzai T, Naito K, Kohno T, Maekawa Y, Takahashi T, Kawamura A, Yoshikawa T, Ogawa S. J Card Fail; 2009 Nov; 15(9):775-81. PubMed ID: 19879464 [Abstract] [Full Text] [Related]
52. Long-term incidence of malignant ventricular arrhythmia and shock therapy in patients with primary defibrillator implantation does not differ from event rates in patients treated for survived cardiac arrest. Backenköhler U, Erdogan A, Steen-Mueller MK, Kuhlmann C, Most A, Schaefer C, Stertmann W, Waas W, Tillmanns H, Waldecker B. J Cardiovasc Electrophysiol; 2005 May 05; 16(5):478-82. PubMed ID: 15877617 [Abstract] [Full Text] [Related]
55. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study. Woo JS, Kim W, Ha SJ, Kim JB, Kim SJ, Kim WS, Seon HJ, Kim KS. Arterioscler Thromb Vasc Biol; 2013 Sep 05; 33(9):2252-60. PubMed ID: 23868944 [Abstract] [Full Text] [Related]
57. [Positive microvolt T-wave alternans as a marker of ventricular arrhythmia trigering during cardioverter-defibrillator implantation]. Wierzbowski R, Michałkiewicz D, Cholewa M, Jacewicz K, Gniłka A, Adamus J. Pol Merkur Lekarski; 2006 Oct 05; 21(124):310-3. PubMed ID: 17205766 [Abstract] [Full Text] [Related]
58. Sustained polymorphic arrhythmias induced by programmed ventricular stimulation have prognostic value in patients receiving defibrillators. Greenberg SL, Mauricio Sánchez J, Cooper JA, Cain ME, Chen J, Gleva MJ, Lindsay BD, Smith TW, Faddis MN. Pacing Clin Electrophysiol; 2007 Sep 05; 30(9):1067-75. PubMed ID: 17725748 [Abstract] [Full Text] [Related]
59. Early mineralocorticoid receptor blockade in primary percutaneous coronary intervention for ST-elevation myocardial infarction is associated with a reduction of life-threatening ventricular arrhythmia. Beygui F, Labbé JP, Cayla G, Ennezat PV, Motreff P, Roubille F, Silvain J, Barthélémy O, Delarche N, Van Belle E, Collet JP, Montalescot G. Int J Cardiol; 2013 Jul 15; 167(1):73-9. PubMed ID: 22200184 [Abstract] [Full Text] [Related]
60. Re-entry using anatomically determined isthmuses: a curable ventricular tachycardia in repaired congenital heart disease. Kapel GF, Reichlin T, Wijnmaalen AP, Piers SR, Holman ER, Tedrow UB, Schalij MJ, Stevenson WG, Zeppenfeld K. Circ Arrhythm Electrophysiol; 2015 Feb 15; 8(1):102-9. PubMed ID: 25422392 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]